enVVeno Medical Corporation
NVNO
$2.35
-$0.13-5.24%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -0.63% | -2.73% | -16.73% | -24.51% | -22.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.59% | -7.93% | -13.87% | -9.28% | 1.23% |
| Operating Income | 5.59% | 7.93% | 13.87% | 9.28% | -1.23% |
| Income Before Tax | 7.22% | 11.68% | 18.08% | 14.05% | 4.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 7.22% | 11.68% | 18.08% | 14.05% | 4.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.22% | 11.68% | 18.08% | 14.05% | 4.67% |
| EBIT | 5.59% | 7.93% | 13.87% | 9.28% | -1.23% |
| EBITDA | 5.52% | 7.94% | 13.99% | 9.38% | -1.21% |
| EPS Basic | 35.27% | 40.48% | 41.39% | 31.26% | 16.77% |
| Normalized Basic EPS | 34.35% | 38.25% | 38.62% | 27.77% | 12.00% |
| EPS Diluted | 35.27% | 40.48% | 41.39% | 31.26% | 16.77% |
| Normalized Diluted EPS | 34.35% | 38.25% | 38.62% | 27.77% | 12.00% |
| Average Basic Shares Outstanding | 38.13% | 46.89% | 40.95% | 30.77% | 20.59% |
| Average Diluted Shares Outstanding | 38.13% | 46.89% | 40.95% | 30.77% | 20.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
